会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 12. 发明授权
    • Palatable suspending vehicle for pharmaceutical ingredients
    • 药物成分的可口悬挂车
    • US08021682B2
    • 2011-09-20
    • US11203520
    • 2005-08-12
    • Joshua RadkeMichael JonesMartin Erickson
    • Joshua RadkeMichael JonesMartin Erickson
    • A61K47/00
    • A61K47/36A61K9/0095A61K9/10A61K31/166A61K31/192A61K31/197A61K31/277A61K31/325A61K47/12A61K47/26A61K47/34
    • The invention relates to a liquid vehicle that can be used to create suspensions and/or solutions of liquid or powdered medications. The vehicle is thixotropic and has improved stability and rheologic characteristics. Vehicles of the invention include an aqueous medium and a suspending agent comprising a polysaccharide having at least 50% glucose repeating saccharide units and at least 90% alpha linkages. The polysaccharide can be a starch, modified starch, or glycogen. The aqueous medium and individual components of the vehicle provide a palatable and easily ingested drug preparation. The invention also provides a vehicle containing an aqueous medium, suspending agent comprising a polysaccharide having at least 50% glucose repeating saccharide units and at least 90% alpha linkages, buffer, and artificial sweetener, the combined suspending vehicle having a pH of about 3 to about 10 and an osmolality of 300 mOmsol or less.
    • 本发明涉及一种液体载体,其可用于产生液体或粉末状药物的悬浮液和/或溶液。 车辆具有触变性,并具有改善的稳定性和流变特性。 本发明的载体包括水性介质和悬浮剂,其包含具有至少50%葡萄糖重复糖单元和至少90%α键的多糖。 多糖可以是淀粉,改性淀粉或糖原。 载体的水性介质和各个组分提供了可口的且容易摄取的药物制剂。 本发明还提供含有水性介质的载体,悬浮剂,其包含具有至少50%葡萄糖重复糖单元和至少90%α键的缓冲剂和人造甜味剂的多糖,所述组合悬浮载体的pH为约3至 约10和重量摩尔渗透压浓度为300mOmsol以下。
    • 13. 发明申请
    • System and method for diet and exercise
    • 饮食和运动的系统和方法
    • US20080162186A1
    • 2008-07-03
    • US12005973
    • 2007-12-28
    • Michael Jones
    • Michael Jones
    • G06Q50/00
    • G06Q30/02G06Q50/22
    • A method for generating and implementing personalized exercise and diet regimens includes initial steps of inputting into an electronic device with a graphical user interface personal data, exercise and diet goals, and a database of food items and related nutritional information; subsequently generating exercise and diet programs correlated to the personal data and goals. Implementing the personalized exercise regimen includes inputting the most recently completed exercise course, outputting a recommended next exercise course correlated with the most recently completed exercise course and the personalized exercise regimen, and performing the exercises. Implementing the diet regimen includes selecting at least one food item which is about to be purchased or consumed, and inputting data identifying the food item and nutritional values. These data are correlated with the recommended diet program; and output is displayed providing recommendations regarding purchase of that food item and suitable alternatives.
    • 用于产生和实施个性化运动和饮食方案的方法包括用图形用户界面个人数据,运动和饮食目标输入电子设备的初始步骤,以及食品和相关营养信息的数据库; 随后产生与个人数据和目标相关的运动和饮食计划。 实施个性化锻炼方案包括输入最近完成的锻炼过程,输出与最近完成的锻炼过程相关的推荐的下一个锻炼过程和个性化锻炼方案,以及执行锻炼。 实施饮食方案包括选择至少一种即将被购买或消费的食品,以及输入识别食物项目和营养价值的数据。 这些数据与推荐的饮食计划相关; 并显示输出,提供有关购买该食品和适当替代品的建议。
    • 17. 发明申请
    • Deployable constrictor for uterine artery occlusion
    • 子宫动脉闭塞可部分收缩
    • US20070173863A1
    • 2007-07-26
    • US11703118
    • 2007-02-06
    • Fred BurbankMichael JonesGreig AltieriEd Olson
    • Fred BurbankMichael JonesGreig AltieriEd Olson
    • A61B17/42
    • A61B17/1227A61B5/026A61B8/06A61B8/12A61B17/1285A61B17/42
    • Devices, systems and methods for occluding blood vessels include a deployable constrictor having opposed pressure-applying portions, a delivery shaft configured to intravaginally advance the constrictor to the patient's cervix, a location sensor configured to detect a blood vessel, a deployment member for deploying the constrictor about the patient's cervix, and optionally a guide. The constrictor has a first configuration to receive a cervix and a second configuration to apply pressure to the cervical area to occlude a uterine artery by compression from the pressure-applying members. The pressure-applying members may be released from the cervix after a limited therapeutically effective time. The invention finds use in, for example, treating uterine disorders and conditions which may be treated by occlusion of the uterine arteries, such as uterine fibroids, dysfunctional uterine bleeding, post-partum hemorrhage, and bleeding associated with caesarian sections.
    • 用于闭塞血管的装置,系统和方法包括具有相对的压力施加部分的可展开的收缩器,配置成将阴囊推进到患者的子宫颈的输送轴,配置成检测血管的位置传感器,用于部署 关于患者的子宫颈的收缩,以及可选的导引。 收缩器具有接收子宫颈的第一构造和第二构造,以通过压力从压力施加构件压迫宫颈区域以阻塞子宫动脉。 压力施加构件可在有限的治疗有效时间后从子宫颈释放。 本发明可用于例如治疗可通过闭塞子宫动脉(例如子宫肌瘤),功能障碍性子宫出血,产后出血以及与切片相关的出血治疗的子宫疾病和病症。
    • 20. 发明申请
    • Temporary catheter for biopsy site tissue fixation
    • 临床导管用于活检部位组织固定
    • US20060205992A1
    • 2006-09-14
    • US11357274
    • 2006-02-17
    • Paul LubockMichael Jones
    • Paul LubockMichael Jones
    • A61N5/00
    • A61M29/02A61B10/0041A61B17/0218A61B90/02A61B2017/00557A61B2017/00796A61B2090/3908A61M25/10A61M29/00A61M2025/1095A61N5/1015
    • Devices and methods are provided for temporarily maintaining access to a body cavity in a targeted tissue region within a patient's body. One embodiment of the catheter device includes an elongated shaft having a proximal shaft section which is flexible enough to be folded or coiled into a configuration for deployment within the patient. An alternate embodiment includes a catheter device having one or more detachable proximal shaft sections and having at least one one-way valve to restrict fluid flow of inflation fluid to flow to the balloon. After deployment of the catheter device completely within the patient, the opening through which the catheter device is deployed is closed, e.g. by sutures, adhesives and the like to minimize infection at the site. Within a few days or weeks after the tissue has been evaluated for cancer, the temporary catheter device may be removed from the patient. If cancer or pre-cancer cells are found in the specimen removed from the cavity, then a radiation balloon catheter or other irradiation device can be inserted into the patient to irradiate tissue surrounding the biopsy cavity to ensure that cancer cells within the tissue surrounding the cavity are killed.
    • 提供了用于暂时维持对患者体内的目标组织区域中的体腔的访问的装置和方法。 导管装置的一个实施例包括细长轴,其具有近侧轴部,该近端轴部足够柔性以折叠或卷绕成用于部署在患者体内的构造。 替代实施例包括具有一个或多个可分离近侧轴部分并且具有至少一个单向阀以限制充气流体流入气囊的流体流动的导管装置。 在将导管装置完全展开在患者体内之后,将导管装置展开的开口关闭,例如, 通过缝线,粘合剂等来最小化现场的感染。 在组织已经被评估癌症后的几天或几周内,临时导管装置可以从患者身上移除。 如果在从腔中取出的样品中发现癌症或癌前细胞,则可以将放射气球导管或其它照射装置插入患者体内以照射活检腔周围的组织,以确保围绕腔的组织内的癌细胞 被杀